etoposide has been researched along with Aging, Premature in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, EJ; Lee, SH; Um, SJ | 1 |
| Caragnano, A; Del Col, L; Maestro, R; Santarosa, M; Tonin, E; Viel, A | 1 |
2 other study(ies) available for etoposide and Aging, Premature
| Article | Year |
|---|---|
CBX8 suppresses Sirtinol-induced premature senescence in human breast cancer cells via cooperation with SIRT1.
Topics: Acetylation; Aging, Premature; Antineoplastic Agents, Phytogenic; Benzamides; Breast Neoplasms; Cell Line, Tumor; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Etoposide; Female; Humans; Naphthols; Polycomb Repressive Complex 1; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; Sirtuin 1; Sirtuins; Tumor Suppressor Protein p53 | 2013 |
Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriers.
Topics: Aging, Premature; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; BRCA1 Protein; Breast Neoplasms; Cell Line, Transformed; Cells, Cultured; Cellular Senescence; Cisplatin; Colony-Forming Units Assay; Cross-Linking Reagents; Doxorubicin; Etoposide; Humans; Mitomycin | 2009 |